Evidence map›Paper›PMID 39132066›Full record

ReviewGastro hep advances2022

Artificial Intelligence and the Future of Gastroenterology and Hepatology.

Daniel D Penrice, Puru Rattan, Douglas A Simonetto

Abstract readReview
In one paragraph

Review in Gastro hep advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel D PenriceDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Puru RattanDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Douglas A SimonettoDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Funding

Liver Cirrhosis Network: Clinical Research Center - Mayo ClinicU01DK130181 · NIDDK · MAYO CLINIC ROCHESTER · PI VIJAY H. SHAH, Douglas A. Simonetto · 2021 to 2026
$1.9M
Randomized Placebo Controlled Pilot Trial to determine the efficacy of an IL22 agonist (F-652) in patients with Alcoholic HepatitisU01AA026886 · NIAAA · MAYO CLINIC ROCHESTER · PI SHAH, VIJAY H., SIMONETTO, DOUGLAS A. · 2018 to 2022
$375k
NIAAA NIH HHS U01 AA026886NIDDK NIH HHS U01 DK130181
6 · The paper itself

Abstract

The integration of artificial intelligence (AI) into gastroenterology and hepatology (GI) will inevitably transform the practice of GI in the coming decade. While the application of AI in health care is not new, advancements are occurring rapidly, and the future landscape of AI is beginning to come into focus. From endoscopic assistance via computer vision technology to the predictive capabilities of the vast information contained in the electronic health records, AI promises to optimize and expedite clinical and procedural practice and research in GI. The extensive body of literature already available on AI applications in gastroenterology may seem daunting at first; however, this review aims to provide a breakdown of the key studies conducted thus far and demonstrate the many potential ways this technology may impact the field. This review will also take a look into the future and imagine how GI can be transformed over the coming years, as well as potential limitations and pitfalls that must be overcome to realize this future.

Indexed as

Big data, Future of healthcare, Machine learning, Neural networks

Identifiers

PMID39132066
PMCPMC11307848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.